Treatment with a retinoic acid-inducible gene I (RIG-I) agonist as monotherapy and in combination with pembrolizumab in patients with advanced solid tumors: results from two phase 1 studies

Víctor Moreno, Emiliano Calvo, Mark R. Middleton, Fabrice Barlési, Caroline Gaudy‐Marqueste, Antoîne Italiano, Emanuela Romano, Aurélien Marabelle, Elliot Chartash, Konstantin Dobrenkov, Heng Zhou, Emilee Connors, Y. Zhang, Martin Wermke